Mundipharma (Pty) Ltd is a leading South African pharmaceutical company specialising in pain management. We commenced operations in September 2011.
We are part of a broader network of independently associated companies that have presence across Europe and throughout the world, including the USA, China, India, Central and South America, Canada, Australia, the Middle East, Japan, Africa and South East Asia.
The success of the independently associated network has been achieved through the passion and commitment of our people. Our deep understanding of patient needs drives us to continually pursue innovative new partnerships and opportunities.
Our people strive to discover and develop new and better ways to treat disease, manage symptoms and improve the quality of life…
Information on Pain
Mundipharma (Pty) Ltd offers a wide array of educational information and other useful resources, which are freely available…
Mundipharma South Africa is proud to provide a broad range of effective products for the treatment of pain.
We have a proud 5 year heritage in pain management in South Africa and are committed to enable healthcare professionals to treat their patients in pain safely and responsibly.
As an organisation that distributes opioids, we believe we have a responsibility to take measures to minimise the risk of misuse and abuse of these medicines while not depriving the patients that need them.
We recognise that misuse and abuse of pain medications can lead to addiction, overdose and death, and we are aware of the public health risk these potent medications can create, especially when they are diverted, misused and/or abused. That is why we are committed to reducing the risk of misuse and abuse through a secure supply chain, appropriate education of healthcare professionals, responsible sales and marketing and close collaboration with government authorities and medical organisations.
We fund educational initiatives in line with industry regulations that clearly communicate the facts about opioid medicines in a balanced and responsible manner, outlining both risks and benefits and helping to ensure that our medicines are prescribed only to the right patient for the right reasons.
We are also committed to finding new approaches to the management of pain, including research into new mechanisms and medicines with the potential to reduce or avoid the need for opioids.